January 27, 2021 | 08:00
Driven by 2020’s highlights, international pharma giants are planning to deliver more vital medicines and vaccines to Vietnam in 2021 to tap into local demands and enable the country to weather future crises.
January 14, 2021 | 14:00
Vietnamese pharmaceutical giants rushed to new business lines in 2020 to create new motivation for growth amid the ongoing pandemic complications, with some changes bringing about better results.
December 09, 2020 | 17:05
Public concerns have ignited over the recall of a popular anti-allergy drug produced by BRV Healthcare, a joint venture between domestic group BV Pharma and UK firm RV Group.
October 22, 2020 | 09:00
Violations in the pharmaceutical industry are seemingly never-ending, with Young Il Pharm, USV Private, and Armepharco being among recent prominent names. However, future wrongdoings may be better resisted when new stricter rules come into effect next month.
September 09, 2020 | 08:00
A number of big pharma companies have been caught violating drug tenders to turn a profit, triggering public concerns over their code of ethics.
August 13, 2020 | 08:00
Amidst lower-than-expected business performance, international pharma giants are betting on COVID-19 vaccine sales, hoping to alter the headwinds from the health crisis to their advantage.
July 30, 2020 | 10:00
Amid Vietnam’s upcoming new rules on drug tenders, multinational pharma giants are advocating price negotiation for an open business environment and predictable policies, in order to make sustainable future investments.
July 23, 2020 | 14:00
Despite strict requirements, international pharma giants like Novartis, AstraZeneca, and Pfizer are rushing to complete all necessary procedures to receive the most sought-after GMP recognition for their manufacturing sites, signalling a hotter tender market in the months to come.
July 17, 2020 | 14:00
The Ministry of Health has made advancements in regulations to facilitate multinational pharmaceutical corporations and to make them align with the EU-Vietnam Free Trade Agreement.
July 16, 2020 | 14:00
International pharma giants like Pfizer, GSK, and Novartis are expected to be strongly hit soon by a price cut under Vietnam’s new tender rules for branded drugs, enabling local patients to receive an increase in pharmaceutical access at affordable prices.
July 14, 2020 | 15:00
After months of challenges and faults in the global ingredient supply chain, peaks and valleys are the landscape for Vietnamese drug giants in their first-half performance, and several factors remain that could damage their operational prospects in the months to come.
June 18, 2020 | 09:00
With SK Group recently joining the mergers and acquisitions race, Vietnam’s pharma and healthcare market is becoming more robust. However, newcomers are expected to face challenges amid increasingly mounting competition in the lucrative pharmaceutical market in the months to come, driven by the enforcement of the EU-Vietnam Free Trade Agreement.
April 02, 2020 | 08:00
Despite having risk management solutions to ensure drug import continuity to Vietnam in response to EU border closures, international pharma giants Sanofi, Zuellig Pharma, Adamed, and Novartis are closely monitoring the situation due to the potential direct impacts on long-term supply security.
March 11, 2020 | 11:00
Facing significant expansion from multinational corporations, Vietnamese drug giants took a hit in 2019 despite new strategies, signalling an uninspiring outlook for future growth.
February 28, 2020 | 12:00
Multinational pharmaceutical groups are seeking ways to support Vietnamese in accessing medical services, and widen their market share in the country in the face of drastic competition.